SMS Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals Limited has submitted a statement to the stock exchange reporting any deviations or variations in the use of proceeds from a recent fund-raising activity (such as a public issue, rights issue, or preferential allotment), as required under Regulation 32 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. Such filings are mandatory for companies that raised capital through specified routes, to disclose whether the actual deployment of funds matches what was originally disclosed in the offer document. The headline does not specify the nature, extent, or quantum of the deviation. The full details of the variation would be available in the attached document filed with the exchange.
For most companies, Reg. 32 filings are routine compliance submissions and may not materially affect the stock price unless the deviation is significant or indicates a change in the originally stated use of funds. Investors should review the detailed document to understand if funds raised have been used differently than promised, which could affect confidence in management's stated plans.